3M Extended Wear Medical Tape Helps Engineers Solve Tough Design Challenges
3M Medical Materials and Technologies announced its 4076 Extended Wear Medical Tape to provide medical device manufacturers and engineers with a long-term wear, acrylic-based adhesive solution. Designed to increase patient comfort and provide a strong and reliable bond in challenging applications, the non-sensitizing, conformable adhesive is intended for long-term wear, providing a bond that is firm yet comfortable so patients may not even realize they are wearing a device.
“Sticking to skin presents a major challenge to the medical device industry,” said Diana Eitzman, Ph.D., director of agile commercialization, 3M Critical and Chronic Care Solutions Division in a press release. “By equipping our customers with the latest adhesive technology, we’re giving them the power to solve their toughest design challenges and positively impact patients’ lives globally.”
The product is compliant with ISO:10993 and ISO:10993-10, medical industry regulations that assess a product’s potential to produce irritation and skin sensitization. The 4076 Extended Wear Medical Tape is approved for use on intact skin.
To learn more about 4076 Extended Wear Medical Tape visit 3M.com/MedTech.
Related Articles
-
Leslie Trigg, CEO of Outset Medical, is the new Chair of The Medical Device Manufacturers Association (MDMA) Board of Directors.
-
Baxter Hillrom is recalling its WatchCare Incontinence Management System (IMS) following reports that the radiofrequency emissions (RF) from WatchCare devices may interfere with other medical devices.
-
The UK MHRA has published “Software and Artificial Intelligence as a Medical Device.” The guidance document assembles previous guidances and regulatory requirements for SaMD and AIaMD devices seeking commercialization in the UK market.
-
The MDDT program was developed in collaboration with the National Institutes of Health’s (NIH’s) National Institute of Drug Abuse (NIDA), National Institute of Dental Craniofacial Research (NIDCR) and National Cancer Institute (NCI) as a way for the FDA to qualify…
